SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AS A PROGNOSTIC FACTOR IN BLADDER CANCER-Reference-Cited by-同舟云学术

SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AS A PROGNOSTIC FACTOR IN BLADDER CANCER

Published:2001-10 Issue:4 Volume:166 Page:1275-1279
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

BERNARDINI S.¹,FAUCONNET S.¹,CHABANNES E.¹,HENRY P.C.¹,ADESSI G.¹,BITTARD H.¹

Affiliation:

1. From the Department of Urology, Centre Hospitalier Universitaire and INSERM, Besançon, France

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Molecular mediators of angiogenesis in bladder cancer;Campbell;Cancer Res,1998

2. Different angiogenic pathways characterize superficial and invasive bladder cancer;O’Brien;Cancer Res,1995

3. Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line;Allen;J Cell Physiol,1993

4. Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence;Miyake;Cancer,1999

5. The angiogenetic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers;O’Brien;Cancer Res,1996

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of vasculogenic mimicry in urological tumors;Frontiers in Oncology;2023-09-21

2. An Overview of Angiogenesis in Bladder Cancer;Current Oncology Reports;2023-04-13

3. Switch Maintenance Therapy for Metastatic Urothelial Carcinoma;Bladder Cancer;2022-12-14

4. Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial;The Lancet Oncology;2022-05

5. Urologic Cancer Molecular Biology;Biomedical Engineering;2021-12-03